Last updated 22 days ago

Study of Dose Confirmation and Safety of Crizanlizumab in Pediatric Sickle Cell Disease Patients

119 patients around the world
Available in Colombia, United States, Brazil
PAREXEL International Colombia S.A.S.
119Patients around the world
Requirements for the patient
To 17 Years
All Gender
Medical requirements
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy